Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
28,234,434
-
Total 13F shares
-
4,558,852
-
Share change
-
+376,417
-
Total reported value
-
$38,476,788
-
Put/Call ratio
-
75%
-
Price per share
-
$8.44
-
Number of holders
-
57
-
Value change
-
+$3,171,664
-
Number of buys
-
33
-
Number of sells
-
22
Institutional Holders of ClearPoint Neuro, Inc. - Common Stock, $0.01 par value (CLPT) as of Q1 2023
As of 31 Mar 2023,
ClearPoint Neuro, Inc. - Common Stock, $0.01 par value (CLPT) was held by
57 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,558,852 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., BROWN ADVISORY INC, MILLENNIUM MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, ESSEX INVESTMENT MANAGEMENT CO LLC, CM Management, LLC, Taylor Frigon Capital Management LLC, Cahill Wealth Management, LLC, and Sentinus, LLC.
This page lists
59
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.